CompletedNCT02952001
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Studying Anterior uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Clearside Biomedical, Inc.
- Principal Investigator
- Thomas Ciulla, MDClearside Biomedical, Inc.
- Intervention
- 4 mg CLS-TA Suprachoriodal Injection(drug)
- Enrollment
- 33 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2018
Study locations (16)
- Retinal Consultants of Arizona, Phoenix, Arizona, United States
- Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View, California, United States
- Retina Group of Florida, Fort Lauderdale, Florida, United States
- Marietta Eye Clinic, Marietta, Georgia, United States
- Valley Eye Physicians and Surgeons, PC, Ayer, Massachusetts, United States
- Bergstrom Eye Research, Fargo, North Dakota, United States
- Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States
- University of Pittsburgh Medical Center Eye Center, Pittsburgh, Pennsylvania, United States
- Texas Retina Associates, Dallas, Texas, United States
- Retina Consultants of Houston, The Woodlands, Texas, United States
- Sri Sankaradeva Nethralaya, Guwahati, Assam, India
- JSS Hospital, Mysore, Karnataka, India
- Sankara Eye Hospital, Coimbatore, Tamil Nadu, India
- King George's Medical University, Lucknow, Uttar Pradesh, India
- Disha Eye Hospitals Pvt. Ltd., Kolkata, India
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02952001 on ClinicalTrials.govOther trials for Anterior uveitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07285070Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisNovaliq GmbH
- RECRUITINGPHASE2NCT07552012A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIUShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07218770A Study of REGN7041 for Active Noninfectious Uveitis in Adult ParticipantsRegeneron Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT07262437Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine ProfilesUniversity of Milan
- ACTIVE NOT RECRUITINGPHASE3NCT06431373A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisPriovant Therapeutics, Inc.
- RECRUITINGNCT07065747Quantification & Classification of Inflammatory Cells in Uveitis Using OCTOregon Health and Science University
- RECRUITINGNCT06720376Observational Prospective Turkish Inception Cohort of Uveitis and SpondyloarthritisMarmara University
- RECRUITINGPHASE3NCT05486468The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentTexas Retina Associates